期刊文献+

以骨转移为首发症状的肾癌长期生存1例报告

下载PDF
导出
摘要 最新研究数据表明,肾癌患者中约8.9%的病人就诊时即发现远处转移,骨转移约占所有转移的23.3%。中位生存期为27.7月,而未经治疗者中位生存期为12月[1-3]。现报道我科1例病人以首发骨转移癌存活7年的病例。
出处 《现代肿瘤医学》 CAS 2012年第4期828-829,共2页 Journal of Modern Oncology
  • 相关文献

参考文献12

  • 1李鸣,何志嵩,高江平,孙颖浩,李长岭,黄翼然,孙光,王国民.多中心肾癌临床特征分析[J].中华泌尿外科杂志,2010,31(2):77-80. 被引量:74
  • 2Flanigan RC,Campbell SC,Clark JI. Metastatic renal cell carcinoma[J].Current Treatment Options in Oncology,2003.385-390.
  • 3Yuasa T,Urakami S,Yamamoto S. Treatment outcome and prognostic factrs in renal cell cancer patients with bone metastasis[J].Clinical and Experimental Metastasis,2011,(04):405-411.
  • 4许健,曹建民,卢光明,孔伟东,高大志,陈波.术前经肾动脉栓塞化疗治疗中晚期肾癌的疗效评价[J].医学研究生学报,2009,22(8):841-842. 被引量:9
  • 5Takashi M,Takagi Y,Sakta T. Surgical treatment of renal cell carcinoma metastases:prognostic significance[J].International Urology and Nephrology,1995.1-8.
  • 6Wedin R,Bauer HC,Wersall P. Failures after operation for skeletal metastatic lesions of long bones[J].Clinical Orthopaedics,1999.128-139.
  • 7Kollender Y,Bickels J,Price WM. Metastatic renal cell carcinoma of bone:indications and techniques of surgical intervention[J].The Journal of Urology,2000.1505-1508.
  • 8Bickels Y,Merimsky O. Bone metastases of renal cell carcinoma:The role of surgery[J].IMAJ,2002.376-337.
  • 9McDermott DF,Regan MM,Clark JI. Randomized phase Ⅲ trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma[J].Journal of Clinical Oncology,2005,(01):133-141.
  • 10Coppin C,Porzsolt F,Awa A. Immunotherapy for advanced renal cell cancer[J].Cochrane Database of Systematic Reviews,2005,(01):CD001425.

二级参考文献18

  • 1陈英鑫,李苏建,卢光明.肾CT和MR灌注成像应用进展[J].医学研究生学报,2007,20(5):535-539. 被引量:15
  • 2Zielinski H, Szmigielski S, Petrovich Z. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma [ J ]. Am J Clin Oncol,2000, 23(1): 6-12.
  • 3Lau W, Blute M, Zincke H . Matched Comparison of Radical Nephrectomy vs Nephron-Sparing Surgery in Patients With Unilateral Renal Cell Carcinoma and a Normal Contralateral [ J ]. J Urol, 2000,75(12) : 1236-1242.
  • 4Obara W, Mizutani Y, Oyama C, et al. Prospective study of combined treatment with interferon alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma. Int J Urol, 2008, 15: 794-799.
  • 5Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioe conomic burden of metastatic renal cell carcinoma (mRCC) : a literature review. Cancer Treat Rev, 2008, 34:193-205.
  • 6Taari K, Perttila I, Nisen H. Laparoscopic versus open nephrectomy for renal cell carcinoma? Scand J Surg, 2004, 93:132-136.
  • 7Rubinstein M, Moinzadeh A, Colombo JR Jr. Energy sources for laparoscopic partial nephrectomy critical appraisal. Int Braz J Urol, 2007, 33:3-10.
  • 8Chapman TN, Sharma S, Zhang S. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology, 2008, 71:287-291.
  • 9Godoy G, O'Malley RL, Taneja SS. Lymph node dissection during the surgical treatment of renal cancer in the modern era. Int Braz J Urol, 2008, 34: 132-142.
  • 10Margulis V, Wood CG. The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J, 2008, 14: 308-314.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部